Evidence map›Paper›PMID 25880777›Full record

ArticleBMC infectious diseases2015

Lipid and glucose alterations in perinatally-acquired HIV-infected adolescents and young adults.

Daniel Blázquez, José Tomás Ramos-Amador, Talía Saínz, María José Mellado, Marta García-Ascaso, María Isabel De José, Pablo Rojo, María Luisa Navarro, María Ángeles Muñoz-Fernández, Jesús Saavedra and 6 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Gut Dysfunction Markers Are Associated With Body Composition in Youth Living With Perinatally Acquired Human Immunodeficiency Virus.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 1 country.

Daniel BlázquezPediatric Infectious Diseases Unit, 12 de Octubre University Hospital Complutense University, Instituto de Investigación Hospital 12 de Octubre, C/Avenida de Córdoba, S/N 28048, Madrid, Spain. danielblazquezgamero@gmail.com.
José Tomás Ramos-AmadorDepartment of Pediatrics, Clínico San Carlos Hospital, Madrid, Spain. josetomas.ramos@salud.madrid.org.
Talía SaínzUnidad de Pediatría Hospitalaria E. Infecciosas y Tropicales Pediátricas, La Paz University Hospital, Madrid, Spain. tsainzcosta@gmail.com.
María José MelladoUnidad de Pediatría Hospitalaria E. Infecciosas y Tropicales Pediátricas, La Paz University Hospital, Madrid, Spain. mariajose.mellado@salud.madrid.org.
Marta García-AscasoDepartment of Pediatrics, Puerta de Hierro University Hospital, Madrid, Spain. martataida@yahoo.es.
María Isabel De JoséUnidad de Pediatría Hospitalaria E. Infecciosas y Tropicales Pediátricas, La Paz University Hospital, Madrid, Spain. maribeldejose@hotmail.com.
Pablo RojoPediatric Infectious Diseases Unit, 12 de Octubre University Hospital Complutense University, Instituto de Investigación Hospital 12 de Octubre, C/Avenida de Córdoba, S/N 28048, Madrid, Spain. pablorojoconejo@netscape.net.
María Luisa NavarroPediatric Infectious Diseases Unit, Gregorio Marañón University Hospital, Madrid, Spain. marialuisa.navarro@salud.madrid.org.
María Ángeles Muñoz-FernándezLaboratorio de Inmunobiología Molecular, Instituto de Investigación Sanitaria Hospital Gregorio Marañón (IISHGM), Madrid, Spain. mmunoz.hgugm@gmail.com.
Jesús SaavedraPediatric Infectious Diseases Unit, Gregorio Marañón University Hospital, Madrid, Spain. jesaave@yahoo.es.
Miguel Angel RoaDepartment of Pediatrics, Móstoles University Hospital, Móstoles, Spain. miguelangel.roa@gmail.com.
Santiago JiménezLaboratorio de Inmunobiología Molecular, Instituto de Investigación Sanitaria Hospital Gregorio Marañón (IISHGM), Madrid, Spain. santiago.jimenezde@salud.madrid.org.
José BeceiroDepartment of Pediatrics, Principe de Asturias University Hospital, Alcalá de Henares, Spain. jbeceiro.hupa@salud.madrid.org.
Luis PrietoDepartment of Pediatrics, Getafe University Hospital, Getafe, Spain. prieto_tatoluis_manuel@hotmail.com.
Milagros García HortelanoDepartment of Pediatrics, Clínico San Carlos Hospital, Madrid, Spain. mgarcial.hciii@salud.madrid.org.
María Isabel González-ToméPediatric Infectious Diseases Unit, 12 de Octubre University Hospital Complutense University, Instituto de Investigación Hospital 12 de Octubre, C/Avenida de Córdoba, S/N 28048, Madrid, Spain. maribelgt@hotmail.com.
Hospital General Universitario Gregorio Marañón · ESHospital Universitario La Paz · ESUniversidad Complutense de Madrid · ESHospital Clínico San Carlos · ESHospital Universitario de Getafe · ESHospital Universitario de Móstoles · ESHospital Universitario Príncipe de Asturias · ESHospital Universitario Puerta de Hierro Majadahonda · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSuccessful antiretroviral therapy (ART) has dramatically reduced mortality among HIV-infected children. However, there is growing concern about long-term effects associated to ART. The aim of this study was to determine the prevalence of metabolic abnormalities in a cohort of perinatally HIV-infected adolescents and young adults and to identify associated factors.

methodsWe present results from a cross-sectional analysis including individuals 12 to 20 years of age, from a prospective, longitudinal cohort of perinatally-acquired HIV-infected children, adolescents and young adults in Madrid. Clinical and immunological data were recorded and complete lipid and glycemic profiles were determined.

resultsNinety-nine adolescents were included, with a median age of 15.3 years [13.6-16.7]. Patients with abnormal levels of lipids were as follows: 27.2% total cholesterol ≥200 mg/dl, 25.9% LDL cholesterol (LDL-c) ≥ 130 mg/dl, 14.1% HDL-C < 35 mg/dl and 39.8% triglycerides ≥ 150 mg/dl. Current use of protease inhibitors (PI) was associated with higher triglyceride values (p = 0.022). Four (4.6%) patients showed fasting glucose ≥ 100 mg/dl and 30.6% presented with insulin resistance (IR) (HOMA-IR over the 90th centile). In the multivariate logistic regression analysis adjusted for sex, age, weight, Tanner stage, protease inhibitors (PI) and nucleoside reverse transcriptase inhibitors (NRTI) treatment length and CD4 nadir, IR was associated with higher waist circumference Z score; OR: 3.92(CI95%: 1.15-13.4) (p = 0.03).

conclusionThere was a high prevalence of insulin resistance and lipid abnormalities in this cohort of perinatally-acquired HIV-infected adolescents. A simple clinical measurement like waist circumference Z score might be a reliable marker and predictor of insulin resistance in these patients.

Indexed as

Infectious Disease Transmission, VerticalInsulin ResistanceAdolescentAntiretroviral Therapy, Highly ActiveBlood GlucoseChildCholesterol, HDLCholesterol, LDLCohort StudiesCross-Sectional StudiesDyslipidemiasFemaleHIV InfectionsHumansLipid MetabolismLogistic ModelsBlood GlucoseCholesterol, HDLCholesterol, LDLProtease InhibitorsReverse Transcriptase InhibitorsTriglycerides

Identifiers

PMID25880777
PMCPMC4384275
OpenAlexW2090709730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.